Aromatherapy and music to reduce stress during cerebral arteriography
Evaluation of the Influence of Aromatherapy and Music Therapy on Stress During the Management of Cerebral Arteriography
NA · University Hospital, Rouen · NCT06425237
This will try aromatherapy, music, or both to reduce stress for adults undergoing cerebral arteriography with local anesthesia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 224 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Rouen (other) |
| Locations | 1 site (Rouen) |
| Trial ID | NCT06425237 on ClinicalTrials.gov |
What this trial studies
This interventional protocol tests whether aromatherapy, music therapy, or their combination can reduce stress and anxiety in adults having cerebral arteriography. Participants receive one of the non-drug interventions from preparation before the procedure through return to the post-interventional surveillance room. Outcomes focus on patient-reported stress and the course of the examination to see if these interventions improve patient comfort and procedural tolerance. The study is conducted at CHU de Rouen.
Who should consider this trial
Good fit: Adults (≥18) scheduled for cerebral arteriography under local anesthesia who can give informed consent, can hear, are not pregnant (or have a negative pregnancy test if of childbearing potential), and do not have allergies to essential oils are ideal candidates.
Not a fit: Patients who require sedation and artificial ventilation, who are deaf or hard of hearing, who have anosmia or a known allergy to essential oils, or who have severe renal insufficiency are unlikely to benefit from these interventions.
Why it matters
Potential benefit: If successful, these simple non-drug measures could lower anxiety, improve patient comfort, and help the procedure proceed more smoothly.
How similar studies have performed: Similar non-drug approaches like music and aromatherapy have shown modest success in reducing procedural anxiety in other medical settings, but data specific to cerebral arteriography are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥ 18 years old) * Patient who is scheduled for a cerebral arteriography with local anaesthesia * Patient who capable to read and understand the patient information and consent. * Patient capable to read and sign the consent form * Patient with social insurance * Woman of childbearing age with effective contraception (see WHO definition), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy) * Negative urine pregnancy test Exclusion Criteria: * Patients who have had a previous cerebral arteriogram * Patient with allergy to iodinated contrast medium * Patient with severe renal insufficiency * Patient requiring sedation and artificial ventilation * Patient who is deaf and/or hard of hearing * Patient with a known allergy to essential oils * Patient with anosmia * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection, under guardianship or curatorship, * Pregnant or breastfeeding woman
Where this trial is running
Rouen
- CHU de ROUEN — Rouen, France (RECRUITING)
Study contacts
- Principal investigator: Magali DUVAL, radiology technician — CHU Rouen
- Study coordinator: Magali DUVAL, radiology technician
- Email: magali.duval@chu-rouen.fr
- Phone: +33 2 32 88 83 83
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Patients Scheduled for Cerebral Arteriography for Diagnostic or Therapeutic Purposes